DASH
Repository logo
Communities & Collections
Browse DASH
DASH Stories
Statistics
  1. Home
  2. Harvard T.H. Chan School of Public Health
  3. SPH Scholarly Articles
  4. Polymorphisms of an Innate Immune Gene, Toll-Like Receptor 4, and Aggressive Prostate Cancer Risk: A Systematic Review and Meta-Analysis

Polymorphisms of an Innate Immune Gene, Toll-Like Receptor 4, and Aggressive Prostate Cancer Risk: A Systematic Review and Meta-Analysis

Open/View files
4215920.pdf (887.75 KB)
Date
2014
Author(s)
Weng, Pei-Hsuan
Huang, Yi-Ling
Page, John H.
Chen, Jen-Hau
Xu, Jianfeng
Koutros, Stella
Berndt, Sonja
Chanock, Stephen
Yeager, Meredith
Witte, John S.
Eeles, Rosalind A.
Easton, Douglas F.
Neal, David E.
Donovan, Jenny
Hamdy, Freddie C.
Muir, Kenneth R.
Giles, Graham
Severi, Gianluca
Smith, Jeffrey R.
Balistreri, Carmela R.
Chen, Yen-Ching
DOI
10.1371/journal.pone.0110569
Publisher
Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Weng, P., Y. Huang, J. H. Page, J. Chen, J. Xu, S. Koutros, S. Berndt, et al. 2014. “Polymorphisms of an Innate Immune Gene, Toll-Like Receptor 4, and Aggressive Prostate Cancer Risk: A Systematic Review and Meta-Analysis.” PLoS ONE 9 (10): e110569. doi:10.1371/journal.pone.0110569. http://dx.doi.org/10.1371/journal.pone.0110569.
Abstract
Background: Toll-like receptor 4 (TLR4) is one of the best known TLR members expressed on the surface of several leukocytes and tissue cells and has a key function in detecting pathogen and danger-associated molecular patterns. The role of TLR4 in the pathophysiology of several age-related diseases is also well recognized, such as prostate cancer (PCa). TLR4 polymorphisms have been related to PCa risk, but the relationship between TLR4 genotypes and aggressive PCa risk has not been evaluated by any systematic reviews. Methods: We performed a systematic review and meta-analysis of candidate-gene and genome-wide association studies analyzing this relationship and included only white population. Considering appropriate criteria, only nine studies were analyzed in the meta-analysis, including 3,937 aggressive PCa and 7,382 controls. Results: Using random effects model, no significant association was found in the ten TLR4 SNPs reported by at least four included studies under any inheritance model (rs2737191, rs1927914, rs10759932, rs1927911, rs11536879, rs2149356, rs4986790, rs11536889, rs7873784, and rs1554973). Pooled estimates from another ten TLR4 SNPs reported by three studies also showed no significant association (rs10759930, rs10116253, rs11536869, rs5030717, rs4986791, rs11536897, rs1927906, rs913930, rs1927905, and rs7045953). Meta-regression revealed that study type was not a significant source of between-study heterogeneity. Conclusions: TLR4 polymorphisms were not significantly associated with the risk of aggressive PCa.
Other Available Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215920/pdf/
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
URI
http://nrs.harvard.edu/urn-3:HUL.InstRepos:13454684
Subjects

Biology and Life Scie...

Evolutionary Biology

Population Genetics

Genetic Polymorphism

Genetics

Cancer Genetics

Physical Sciences

Mathematics

Statistics (Mathemati...

Statistical Methods

Meta-Analysis

Systematic Reviews

Collection
SPH Scholarly Articles
Metrics
Repository logo
  • CONTACT US
  • OSRDS
  • ABOUT DASH
  • DEPOSITING TO DASH
  • TERMS OF USE
  • REQUEST A WAIVER
  • TAKE DOWN POLICY
  • NAME CHANGE POLICY
  • HARVARD OA POLICIES
  • DASH SUBMITTER AGREEMENT
  • Accessibility
  • Privacy
Creative Commons License BY
Creative Commons Attribution 4.0 International License

Except where otherwise noted, this work is subject to a Creative Commons Attribution 4.0 International License,
which allows anyone to share and adapt our material as long as proper attribution is given.
For details and exceptions, see the Harvard Library Copyright Policy
©2024 Presidents and Fellows of Harvard College.